Pages that link to "Q96644314"

The following pages link to Mario Sanchez-Borges (Q96644314):

Displaying 26 items.

• Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) (Q26740215) (← links)
• Meteorological conditions, climate change, new emerging factors, and asthma and related allergic disorders. A statement of the World Allergy Organization (Q28383187) (← links)
• Climate change, allergy and asthma, and the role of tropical forests (Q29353586) (← links)
• Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement (Q30371972) (← links)
• Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA# and GA2LEN/HANNA* (Q34188879) (← links)
• EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria (Q35004484) (← links)
• EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria (Q35004490) (← links)
• Diagnosis and treatment of urticaria and angioedema: a worldwide perspective (Q36834774) (← links)
• Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs (Q38049856) (← links)
• The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update (Q38208428) (← links)
• Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria (Q38217720) (← links)
• Integrated care pathways for airway diseases (AIRWAYS-ICPs). (Q42210687) (← links)
• Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). (Q42320566) (← links)
• Erratum to: Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement (Q42331374) (← links)
• The EAACI/GA²LEN/EDF/WAO Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. The 2017 Revision and Update (Q48517489) (← links)
• Wytyczne EAACI/GA2LEN/EDF/WAO dotyczące definicji, klasyfikacji, rozpoznawania i leczenia pokrzywki: weryfikacja z 2013 roku z poprawkami (Q56984084) (← links)
• The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update (Q56984093) (← links)
• ARIA Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology (Q57066674) (← links)
• ARIA pharmacy 2018 "Allergic rhinitis care pathways for community pharmacy": AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD (Q64360540) (← links)
• 2019 ARIA Care pathways for allergen immunotherapy (Q64447216) (← links)
• ARIA pharmacy 2018 “Allergic rhinitis care pathways for community pharmacy” (Q64447220) (← links)
• Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020 (Q90734618) (← links)
• Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence (Q90807713) (← links)
• Definition, aims, and implementation of GA2 LEN/HAEi Angioedema Centers of Reference and Excellence (Q91574219) (← links)
• ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice (Q96226501) (← links)
• Global implementation of the world health organization's international classification of diseases (ICD)-11: the allergic and hypersensitivity conditions model (Q96644316) (← links)